0001127602-22-006283.txt : 20220223
0001127602-22-006283.hdr.sgml : 20220223
20220223162211
ACCESSION NUMBER: 0001127602-22-006283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220221
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Troyen A
CENTRAL INDEX KEY: 0001351402
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 22664038
MAIL ADDRESS:
STREET 1: AETNA INC.
STREET 2: 151 FARMINGTON AVENUE
CITY: HARTFORD
STATE: CT
ZIP: 06156
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-21
0000064803
CVS HEALTH Corp
CVS
0001351402
Brennan Troyen A
ONE CVS DRIVE
WOONSOCKET
RI
02895
1
EVP and Chief Medical Officer
Common Stock
2022-02-21
4
A
0
171944
0
A
312815.059
D
Common Stock (restricted)
4805
D
Stock Option
104.82
2017-04-01
2023-04-01
Common Stock
53772
53772
D
Stock Option
78.05
2018-04-03
2024-04-03
Common Stock
75134
75134
D
Stock Option
62.21
2019-04-01
2025-04-01
Common Stock
21894
21894
D
Stock Option
54.19
2020-04-01
2029-04-01
Common Stock
80803
80803
D
Stock Option
58.34
2021-04-01
2030-04-01
Common Stock
84478
84478
D
Stock Option
74.30
2022-04-01
2031-04-01
Common Stock
99344
99344
D
Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Option became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Options became exercisable in four equal annual installments, commencing 4/1/2021.
Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
/s/ Troyen Brennan
2022-02-23